Typical Metformin Dosage in Psychiatry
In psychiatric practice, metformin is typically dosed at 1,000 mg twice daily (2,000 mg/day total) for managing antipsychotic-induced weight gain, with gradual titration starting from 500 mg daily to minimize gastrointestinal side effects.
Dosing Regimen
The most robust evidence comes from the largest randomized controlled trial in psychiatric patients, which used metformin titrated to 1,000 mg twice daily over 16 weeks in patients with schizophrenia or schizoaffective disorder taking antipsychotics 1. This dosing achieved statistically significant weight loss of 3.0 kg compared to placebo.
Standard Titration Schedule
Based on guideline recommendations and clinical trial data 1, 2:
- Start: 500 mg once daily with a meal (breakfast or dinner)
- Week 2: Increase to 500 mg twice daily
- Week 4: Increase to 1,000 mg twice daily (target dose)
- Maximum dose: 2,000 mg/day in divided doses
The 2025 INTEGRATE schizophrenia guidelines specifically recommend starting at 500 mg once daily, then increasing in 500 mg increments every 2 weeks up to 1 g twice daily, dependent on tolerability 2. Modified-release formulations should be used when available to minimize gastrointestinal side effects.
Dosing Variations by Clinical Context
Prevention of Weight Gain (Co-commencement)
When starting metformin simultaneously with antipsychotics known to cause weight gain (particularly olanzapine or clozapine):
- 750 mg daily has shown efficacy in preventing weight gain 1
- One trial used 750 mg/day and prevented 5 kg of weight gain compared to placebo over 12 weeks 1
Treatment of Established Weight Gain
For patients who have already gained significant weight on antipsychotics:
- Target dose: 1,000 mg twice daily (2,000 mg/day) 1
- Some studies used ranges of 850-2,550 mg/day 1
- The 750 mg/day dose combined with lifestyle intervention was most effective in one Chinese study 1
Duration of Treatment
Metformin maintains its weight-reducing effects from 12 to 24 weeks 3. The evidence suggests:
- Minimum effective duration: 12 weeks
- Optimal duration studied: 16 weeks (largest trial) 1
- Effects sustained through 24 weeks 3
Critical Safety Monitoring
Before initiating metformin in psychiatric patients 2, 4:
Mandatory baseline assessments:
- Renal function (eGFR) - contraindicated if eGFR <30 mL/min/1.73m²
- Liver function tests
- Vitamin B12 levels
Ongoing monitoring:
- Annual HbA1c, renal function, liver function, and vitamin B12 2
- Reassess dose if eGFR decreases to <45 mL/min/1.73m² 5
Common Pitfalls and Practical Considerations
Gastrointestinal side effects are the primary limitation, occurring in up to 64.9% of patients 6. To minimize these:
- Use modified-release formulations when available 2
- Take with meals 7, 8
- Titrate slowly over 2-4 weeks 8, 2
Contraindications to avoid 5, 4:
- Renal impairment (eGFR <30 mL/min/1.73m²)
- Hepatic impairment or advanced cirrhosis
- Cardiac failure
- Conditions predisposing to lactic acidosis
The 2023 JAMA obesity management review notes metformin's starting dose of 500 mg/day with a maximum of 2,500 mg/day for general obesity management 7, though psychiatric practice typically targets 2,000 mg/day as the therapeutic ceiling based on the weight of evidence in this population.
Evidence Quality
The dosing recommendations are supported by multiple RCTs specifically in psychiatric populations 1, with the 1,000 mg twice daily regimen having the strongest evidence base from the largest trial (n=148) 1. A 2024 meta-analysis of 20 studies with 1,070 patients confirmed metformin's efficacy at these doses for antipsychotic-induced weight gain 3.